gptkbp:instanceOf
|
gptkb:chemical_compound
central nervous system depressant
|
gptkbp:abusePotential
|
high
|
gptkbp:antidote
|
supportive care
benzodiazepines for agitation
|
gptkbp:aroma
|
slightly salty
|
gptkbp:boilingPoint
|
204 °C
|
gptkbp:CASNumber
|
591-81-1
|
gptkbp:category
|
neurotransmitter
prodrug of GABA
|
gptkbp:chemicalFormula
|
C4H8O3
|
gptkbp:color
|
colorless
|
gptkbp:contraindication
|
gptkb:beer
gptkb:CNS_depressants
|
gptkbp:discoveredBy
|
gptkb:Alexander_Zaytsev
|
gptkbp:discoveredIn
|
1874
|
gptkbp:excretion
|
kidneys
|
gptkbp:flavor
|
slightly salty
|
gptkbp:foundIn
|
mammalian brain
|
gptkbp:halfLife
|
30-60 minutes
|
gptkbp:IUPACName
|
gptkb:4-hydroxybutanoic_acid
|
gptkbp:legalStatus
|
controlled substance in many countries
|
gptkbp:mainStreet
|
gptkb:Georgia_Home_Boy
gptkb:liquid_ecstasy
G
|
gptkbp:mechanismOfAction
|
GABA-B receptor agonist
GHB receptor agonist
|
gptkbp:medicalBrandName
|
gptkb:Xyrem
|
gptkbp:meltingPoint
|
98.5 °C
|
gptkbp:metabolism
|
liver
|
gptkbp:molecularWeight
|
104.1 g/mol
|
gptkbp:otherName
|
gptkb:gamma-Hydroxybutyric_acid
gptkb:sodium_oxybate
|
gptkbp:overdoseSymptoms
|
respiratory depression
|
gptkbp:riskFactor
|
addiction
overdose
withdrawal symptoms
|
gptkbp:routeOfAdministration
|
oral
intravenous
|
gptkbp:sideEffect
|
nausea
dizziness
loss of consciousness
drowsiness
|
gptkbp:solubility
|
highly soluble in water
|
gptkbp:usedAs
|
analgesic
recreational drug
treatment for narcolepsy
|
gptkbp:usedFor
|
treatment of cataplexy
treatment of excessive daytime sleepiness
|
gptkbp:bfsParent
|
gptkb:Great_Highland_bagpipe
|
gptkbp:bfsLayer
|
6
|